Active ingredientMethazolamideCat. No. P-M079-001CAS 554-57-4Family · Pharmaceutical analytical standards
Methazolamide
An inhibitor of carbonic anhydrase, the enzyme that turns carbon dioxide and water into carbonic acid, structurally related to acetazolamide and the sulfonamides: it lowers the pressure inside the eye. It was approved in the US in 1959 for glaucoma. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?A 1950s medicine with a possible new role: in 2024 a study published in Nature Chemical Biology suggested it could counter the toxicity of the tau protein, which is involved in Alzheimer's disease.
Go to the active ingredient →Active ingredientMethazolamideCat. No. P-M079-001CAS 554-57-4
Isotopically labelledMethazolamide-d6Cat. No. P-M079-002CAS 1795142-30-1
ImpurityMethazolamide Impurity 1Cat. No. P-M079-003
ImpurityMethazolamide Sulfonic AcidCat. No. P-M079-004CAS 1312679-00-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.